Terms: = Lymphoma AND ERCC3, RAD25, 2071, ENSG00000163161, GTF2H, TFIIH, BTF2, P19447, XPB AND Treatment
6 results:
1. Interruption of BTK inhibitor improves response to SARS-CoV-2 booster vaccination in patients with CLL.
Tomasulo E; Paul S; Mu R; Tian X; Chen J; Pleyer C; Wiestner A; Sun C
Leuk Lymphoma; 2023 Dec; 64(14):2306-2315. PubMed ID: 37732614
[TBL] [Abstract] [Full Text] [Related]
2. Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC.
Ma X; Zhang K; Xu J; Gao H; Yang S; Qin H; Wang H; Gao F; Liu X
Thorac Cancer; 2023 Jul; 14(20):1980-1990. PubMed ID: 37265111
[TBL] [Abstract] [Full Text] [Related]
3. Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum Chemotherapy.
Schwartzberg L; Korytowsky B; Penrod JR; Zhang Y; Le TK; Batenchuk C; Krug L
Clin Lung Cancer; 2019 Jul; 20(4):287-296.e4. PubMed ID: 31130450
[TBL] [Abstract] [Full Text] [Related]
4. Cancer screening practices of cancer survivors: population-based, longitudinal study.
Grunfeld E; Moineddin R; Gunraj N; Del Giudice ME; Hodgson DC; Kwon JS; Elit L
Can Fam Physician; 2012 Sep; 58(9):980-6. PubMed ID: 22972732
[TBL] [Abstract] [Full Text] [Related]
5. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
[TBL] [Abstract] [Full Text] [Related]
6. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.
Thomas X; Thiebaut A; Olteanu N; Danaïla C; Charrin C; Archimbaud E; Fiere D
Hematol Cell Ther; 1998 Jun; 40(3):119-28. PubMed ID: 9698220
[TBL] [Abstract] [Full Text] [Related]
